Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that patients with Telogen effluvium had significantly higher levels of heavy metals, such as cadmium and lead, compared to controls.

In this study, chronic telogen effluvium and female pattern hair loss were the most common types of non-scarring diffuse hair loss among Indian women aged 15-45, with anemia frequently present across cases.

This study found that female pattern hair loss is the most common type of diffuse hair loss in women, with significant associations observed between chronic telogen effluvium, low iron levels, and high total iron-binding capacity.

This study found a significant association between iron deficiency anemia and telogen effluvium in women of childbearing age, with noticeable improvement in hair loss after four weeks of oral iron supplementation.

This review discusses the diagnosis and treatment of diffuse alopecia but reports no new results; the authors emphasize the importance of detailed history and examination for accurate diagnosis.

This study found that most cases of telogen effluvium in Iraqi women had no clear triggering factor, although significant hair thinning was uncommon.

In this study, most Iraqi women with telogen effluvium had no identifiable triggers, though severe stress was noted in 21% of cases prior to the condition onset.

This article reviews the diagnosis and causes of different types of alopecia, presenting no new clinical findings.

This diagnostic discussion reports that diffuse alopecia areata was identified in a patient with diffuse hair loss, based on specific histopathological features observed in a biopsy.

Patient history is key in diagnosing hair loss types.

This article is a case report on severe hair loss due to telogen effluvium occurring during inpatient rehabilitation and does not provide new clinical results.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

This case study reports a pattern of psychogenic telogen effluvium with temporary hair loss following a C5 complete spinal cord injury, recovering fully except for minor hair loss at the occiput.

This study found that applying a surfactant solution with 2.5% selenium disulfide to the back of guinea pigs significantly increased telogen hair, which may relate to observations of diffuse hair loss in humans under intense exposure conditions.

Collagen CLR and placenta extract may help treat diffuse hair loss.

This study suggests that chronic telogen effluvium may be due to a reduction in the variance of anagen duration, resulting in recurrent hair shedding with minimal long-term hair volume loss.

This study found that hair follicles on the anterior scalp may be more vulnerable to acute telogen effluvium than those on the occipital scalp.

This review examines chronic telogen effluvium, highlighting its distinctive features and the need for reassurance about its non-progressive nature, but reports no new clinical results.

This study reports that dermoscopy is a useful diagnostic tool for distinguishing acute diffuse and total alopecia of the female scalp from female pattern hair loss by identifying specific hair features.

This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.

This study found a significant association between low serum ferritin levels and chronic telogen effluvium in menstruating women, with iron treatment improving hair growth in those affected.

This article discusses the challenges in diagnosing and treating diffuse hair loss in women and emphasizes the importance of distinguishing between androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium, but reports no new clinical results.

This study found low serum ferritin and vitamin B12 levels in a significant portion of women with chronic telogen effluvium, while vitamin D deficiency was less common.

This study found that a recent outbreak of diffuse hair loss in Maharashtra's Buldhana district was linked to anagen effluvium, possibly caused by high selenium levels, along with strontium and zinc excess in patients' serum and local water sources.

In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.

This study concluded that diffuse hair loss in women has a moderate to severe impact on their quality of life, especially among younger women and those with prolonged duration of hair loss.

This case report describes a 42-year-old Indian female with acute diffuse and total alopecia who experienced sudden diffuse hair loss within one day, differentiating it from telogen effluvium through specific dermoscopic findings.

This study found that females with chronic diffuse hair loss, including chronic telogen effluvium and female pattern hair loss, had significantly lower serum ferritin levels compared to controls, suggesting a strong association between decreased iron stores and hair loss.

This study observed that triple horizontal scalp biopsies provided a more accurate diagnosis of female pattern hair loss in women than a single horizontal biopsy, especially for those with advanced hair loss.

This study reports that nonscarring diffuse hair loss in women is most common in the 21-40 age group, with low serum ferritin, vitamin B12, and vitamin D3 levels contributing to its pathogenesis.